FDA 483 - Integra CI Inc. dba Integra Neurosciences PR, Inc. - August 23, 2019
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Integra CI Inc. dba Integra Neurosciences PR, Inc. in Anasco, PR, revealed five significant deficiencies in its quality system for medical device manufacturing. The firm failed to adequately establish procedures for corrective and preventive actions, design transfer, process validation, finished device acceptance, and purchasing controls. These issues are primarily related to problems with external cerebrospinal fluid drainage systems, including stopcock breakage and leaks.
- Inspection Date
- August 23, 2019
- Product Type
- Device
ID · a44af8f5-9b93-44e7-b0cd-950c3e171542